← Back to Clinical Trials
Recruiting NCT06863168

NCT06863168 Cigarillo Public Education Messaging for Black Young Adults

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06863168
Status Recruiting
Phase
Sponsor Drexel University
Condition Cigarillo Smoking
Study Type INTERVENTIONAL
Enrollment 360 participants
Start Date 2025-04-17
Primary Completion 2025-11-30

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 30 Years
Study Type INTERVENTIONAL
Interventions
Cigarillo Health Harm and Nicotine Addiction MessagingCigarillo Health Harm and Nicotine Addiction Messaging Contextualized to Outcome Expectancies

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 360 participants in total. It began in 2025-04-17 with a primary completion date of 2025-11-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This is a 3-arm randomized controlled trial to examine the effects of cigarillo public education messages among Black young adults who are at-risk for established cigarillo smoking. The primary outcomes are cigarillo harm perceptions, outcome expectancies, and use intentions at 3-month follow-up. Exploratory outcomes are use behaviors (cigarillo smoking initiation and use behaviors) measured at 3-month follow-up. These outcomes will also be measured at 1-month follow-up time point.

Eligibility Criteria

Inclusion Criteria: * Be between 18 to 30 years of age; * Self-identify as non-Hispanic Black or African American ethnicity and race, respectively; * Must be able to communicate, read, and write in the English language; * Have never used cigarillos fairly regularly based on a valid measure but are deemed susceptible to cigarillo smoking based on a valid 4-item susceptibility measure; OR currently smokes cigarillos some days but not every day (i.e., experimentation) * And must have no history of fairly regular use of any other tobacco products (i.e., little cigars, large cigars, cigarettes, hookah tobacco, electronic vaping products, smokeless tobacco, and heated tobacco products) Exclusion Criteria: * Persons who are younger than 18 years of age or older than 30 years of age. * Persons who do not self-identify as a non-Hispanic Black/African American person. * Persons who are not deemed susceptible based on a valid susceptibility measure (i.e., not susceptible to cigarillo smoking) * Persons who have fairly regular use of any tobacco product (i.e., persons with a former or current established pattern of any tobacco use including cigarillos, little cigars, large cigars, cigarettes, hookah tobacco, electronic vaping products, smokeless tobacco, and heated tobacco products) * Persons who are unable to read, write, and communicate in English language. The informed consent and other materials, including surveys, are only available in the English language for this study. Additionally, trained staff members that will communicate and interact with participants for this study can only speak in English.

Contact & Investigator

Central Contact

Lilianna Phan, PhD, MPH, MS

✉ lp954@drexel.edu

📞 267-359-6069

Frequently Asked Questions

Who can join the NCT06863168 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 30 Years, studying Cigarillo Smoking. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06863168 currently recruiting?

Yes, NCT06863168 is actively recruiting participants. Contact the research team at lp954@drexel.edu for enrollment information.

Where is the NCT06863168 trial being conducted?

This trial is being conducted at Philadelphia, United States, Philadelphia, United States.

Who is sponsoring the NCT06863168 clinical trial?

NCT06863168 is sponsored by Drexel University. The trial plans to enroll 360 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology